Farag Ahmad M, Mayhoub Abdelrahman S, Barakat Saber E, Bayomi Ashraf H
Department of Chemistry, Faculty of Science, Cairo University, Giza 12613, Egypt.
Bioorg Med Chem. 2008 Jan 15;16(2):881-9. doi: 10.1016/j.bmc.2007.10.015. Epub 2007 Oct 12.
The versatile, hitherto unreported 4-acetyl-5-methyl-1-phenyl-3-phenylcarbamoyl-1H-pyrazole (3) was prepared via the reaction of 2-(2-phenylhydrazono)-2-chloro-N-phenylacetamide with pentan-2,4-dione in the presence of sodium ethoxide. Reaction of 3 with dimethylformamide-dimethylacetal (DMF-DMA) furnished the corresponding 4-[(E)-3-(dimethylamino)acryloyl]-5-methyl-1-phenyl-3-phenylcarbamoyl-1H-pyrazole (5). The latter product underwent regioselective 1,3-dipolar cycloaddition with some nitrilimines to afford the non-isolable dihydropyrazole intermediates which then lose dimethylamine yielding the corresponding pyrazole derivatives. The preliminary screening for the antitumor activity of all newly synthesized compounds was carried out against Ehrlich Ascites Carcinoma tumor cells.
通过2-(2-苯基肼基)-2-氯-N-苯基乙酰胺与戊烷-2,4-二酮在乙醇钠存在下反应,制备了多功能的、迄今未报道的4-乙酰基-5-甲基-1-苯基-3-苯基氨基甲酰基-1H-吡唑(3)。3与二甲基甲酰胺-二甲基缩醛(DMF-DMA)反应得到相应的4-[(E)-3-(二甲基氨基)丙烯酰基]-5-甲基-1-苯基-3-苯基氨基甲酰基-1H-吡唑(5)。后一种产物与一些腈亚胺进行区域选择性1,3-偶极环加成反应,得到不可分离的二氢吡唑中间体,然后失去二甲胺,生成相应的吡唑衍生物。对所有新合成的化合物进行了针对艾氏腹水癌细胞的抗肿瘤活性初步筛选。